ATB Therapeutics
Founded 2018 · 38 employees on LinkedIn · 3 known investors
ATB Therapeutics develops targeted antibody therapies, including its "atbody" format, for hematological malignancies, autoimmune diseases, and solid tumors. The company also operates a plant-based manufacturing technology platform for producing these therapeutics.
Investors · 3
Frequently asked questions
- What does ATB Therapeutics do?
- ATB Therapeutics develops targeted antibody therapies, including its "atbody" format, for hematological malignancies, autoimmune diseases, and solid tumors. The company also operates a plant-based manufacturing technology platform for producing these therapeutics.
- Who are ATB Therapeutics's investors?
- ATB Therapeutics's investors include MRL Ventures Fund, V-Bio Ventures, VIVES Partners.